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ABSTRACTS0269: GASTROINTESTINAL STROMAL TUMOUR OF THE RECTUM:
A REVIEW OF SURGICAL TREATMENT, OUTCOMES AND THE ROLE OF
IMATINIB
M.J. Wilkinson, J.E.F. Fitzgerald, D.C. Strauss, A.J. Hayes, J.M. Thomas. The
Royal Marsden Hospital NHS Foundation Trust, London, UK
Aims: Gastrointestinal stromal tumours (GISTs) of the rectum are rare,
accounting for only 0.1% of all rectal tumours. This study investigates the
presentation, management and outcomes of rectal GISTs at a specialist
unit.
Methods: Retrospective cohort study analysing a prospectively main-
tained database at a tertiary referral centre from Jan 2001 - Jan 2012.
Results: A total of 14 patients (6 female, 8 male), presented with a pri-
mary rectal GIST. Commonest presenting symptoms were rectal bleeding
(n¼6) and tenesmus (n¼6). Median tumour size at presentation: 8cm
(range 2 - 12cm). 12 patients received neoadjuvant imatinib; median
reduction in tumour size 2.8cm (range 0.5 - 5.6cm); p ¼ 0.001. Surgical
resection was performed in 6 of the 14 patients (2 patients declined
surgery and 6 are continuing imatinib to downsize). Complete macro-
scopic clearance was obtained in 100% of patients. On follow up, 12
patients are alive without metastases: median follow-up 31.3 months.
There were 2 deaths from unrelated causes. The remaining 5 patients
operated on are disease free (median DFS ¼ 36.2 months).
Conclusions: Biopsy is essential in establishing the diagnosis. Neoadjuvant
imatinib substantially downsizes rectal GISTS which may permit less
invasive surgery. Favourable outcomes can be achieved for rectal GISTs in
specialist centres.
0283: A PROPOSED STANDARD FOR PRE-OPERATIVE LAPAROSCOPIC
COLORECTAL CANCER RESECTION ENDOSCOPIC TATTOOING.
IDENTIFICATION OF MODIFIABLE PRACTICES AT AN ENHANCED
RECOVERY CANCER CENTRE
Ajay Sud, Arkeliana Tase, Elinor Baker, Santanu Bhattacharjee, Shiva
Dindyal, Stefano Andreani. Whipps Cross University Hospital, London, UK
Aims: The National Bowel Cancer Screening Program speciﬁes a 100%
target for tattooing of suspected malignant lesions. There remains no
all-inclusive guideline for colorectal tattooing. We aim to identify factors
contributing to suboptimal practice.
Methods: The data collected incorporated retrospective analysis of all 144
colorectal surgery patients at Whipps Cross Hospital whom underwent
oncological colorectal resections for tenmonths from January 2008 and six
months from June 2010.
Results: In 2008 and 2010, 39% and 52% respectively, of our patients
received pre-operative tattooing. In 2008 and 2010, 30% and 50% respec-
tively of lesions were only documented to be distally tattooed. The mean
number of days between their pre-operative endoscopy to surgery in 2010
was 69 days. In 2008 consultant gastroenterologists tattooed 70% of
suspect lesions, but by 2010 this reduced to 36%. Only 40%were underwent
solely distal tattooing, and 22% of ulcerating lesions were tattooed.
Conclusions: Surgeons are the direct recipients of suboptimal tattooing.
They are best placed to lead the colonoscopy community to ensure efﬁ-
cacious tattooing practices, enabling optimal uncomplicated oncological
resection. The standard for practice should be a recent distal ‘360-degree'
tattoo with one vial per 30 degrees, to all suspicious lesions, irrespective to
the endoscopic morphology.
0316: IROBOT - INITIALIZING A ROBOTIC COLORECTAL SERVICE
Faira Eldriana Rizal, Benjamin Stubbs, P. Mathur, Colin Elton, Daren
Francis. Department of Coloproctology, Barnet and Chase Farm Hospital,
London, UK
Aims: Robotic surgery has potential advantages in the difﬁcult pelvis,
however use in coloproctology has been limited. We describe our early
experience.
Methods: 3 colorectal surgeons gained certiﬁcation as console surgeons on
the da Vinci robot and a mentoring programme was undertaken with an
experienced robotic colorectal surgeon. (2 anterior resections at the
mentor's hospital followed by 2 ventral mesh rectopexies performed at our
trust.) Data was collected prospectively on all cases performed over 1 year.
Results: 12 robotic colorectal procedures were performed (6 ventral
rectopexies, 5 anterior resections and 1 ultra-low Hartmann's). Nointra-operative complications occurred, with one conversion to open
surgery. Mean operative times were: mesh rectopexy 270 minutes
(range 205-310), anterior resection 366 minutes (304-408) and Hart-
mann's 355 minutes. Mean length of stays were: ventral rectopexy 2
days (range 1-3), anterior resection 7.6 days (5-10) and Hartmann's was
8 days. 1 post-operative ileus occurred with no other post-operative
complications. All patients with rectal cancer had good oncological
clearance on histology.
Conclusions: Initiation of a robotic colorectal service is a safe and feasible
option within a supervised mentoring programme. We anticipate an
improvement in operating time with increased experience, however
further studies into economic viability are needed.
0324: FAMILIAL ADENOMATOUS POLYPOSIS RELATED DESMOIDS
PRESENTING WITH AIR-FLUID LEVEL – A CLINICAL REVIEW AND
MANAGEMENT ALGORITHM
Santosh Bhandari, Pravin Ranchod, Ashish Sinha, Arun Gupta, Susan
Clark, Robin Phillips. St Mark's Hospital, Harrow, Middlesex, UK
Aim:Familial adenomatous polyposis (FAP) related desmoid tumors (DT)
can present with a liqueﬁed centre containing gas, accompanied by
abdominal pain and sepsis. We present our experience of managing these
desmoids grouped together as ‘intra-abdominal desmoids (IAD) with
air-ﬂuid level’.
Material and methods:Retrospective review of prospectively maintained
polyposis registry database was conducted at a tertiary referral centre
specializing in FAP and desmoid disease.
Results:A total of nine patients had an IAD with air-ﬂuid level, seven were
female. Age range at diagnosiswas 20-41 years. Themedian time taken from
primary surgery to DT development was 24 months (range 0 – 48 months),
and themedian time for further progression to air-ﬂuid levelwas 24months
(range 0 – 226 months). DT size ranged from 10cm to greater than 20cm in
diameter. Two patients were successfully managed with antibiotics alone,
and two patientswith percutaneous drainage and antibiotics. The other ﬁve
patients required surgical intervention involving either excision or drainage
with or without proximal defunctioning/exclusion.
Conclusions:The majority of IAD patients with an air-ﬂuid level require
surgical intervention. Antibiotics and percutaneous drainage are only
successful in a limited number of patients. We present our current treat-
ment algorithm based on this experience.
0362: LOCAL RECURRENCE (LR) RATES AFTER OPERABLE RECTAL
CANCER SURGERY
Robert Nadler, Daniel Brown, Sue Hignett, Carol Makin, Goldie
Khera. Wirral Hospital, Liverpool, UK
Aims: LR rates following curative resection have been reported to be
between 2.4 - 50% with LR rates hypothesised to be higher for abdomi-
noperonial resection (APR) vs anterior resection (AR). We analysed our LR
rates over an 11 year period
Methods: Between 1999 and 2010, 312 patients with operable rectal
cancer (<15cm from the anal verge) were followed up to determine local
or regional recurrence. Total Mesorectal Excision (TME) principles were
adhered to, together with tailored neo and adjuvant chemo-radiotherapy
protocols.
Results: Age range 38 - 98 years, 60% male, follow-up for up to 11 years.
Rates of APR were 23%, AR 56% and Hartmann's 8%. Total LR rates were 5%.
In those developing LR, distance from the anal verge was 2-15cm (median
6cm), with AR being performed as low as 3cm. The distant recurrence rates
were 18%.
Conclusions: Concerns have been raised in the Association of Colo-
proctology of Great Britain and Ireland guidelines regarding the plane of
dissection and potentially higher recurrence rates in APR vs AR. Our study
demonstrates however, that with the TME technique both APR and ultra-
low AR can be performed with low LR, highlighting the importance of
specialist rectal surgeons in cancer surgery.
0384: LAPAROSCOPIC TECHNIQUES MAY MINIMIZE THE SHORT-TERM
IMPACT OF REPEATED SURGICAL RESECTION IN THE MANAGEMENT
OF CROHN'S DISEASE
Christopher Whitﬁeld, Richard Slater. Rotherham NHS Foundation Trust,
Rotherham, UK
Abstracts / International Journal of Surgery 10 (2012) S1–S52 S25
ABSTRACTSIntroduction: Multiple surgical resections may be necessary in chronic
Crohn's disease management. Laparoscopic techniques offer a minimally
invasive approach. The 5-year experience of a Consultant Colorectal
Surgeon in a District General Hospital is described. Short-term outcomes of
elective laparoscopic procedures are emphasized.
Methods: Patient and operative data were extracted from a prospective
database for the period November 2007 to November 2011.
Results: 14 elective laparoscopic procedures were performed on 13 patients
(7 male, 6 female) with Crohn's disease. Median age was 42.8 years (range
17.3-68.9 years). The procedures comprised: 11 right-hemicolectomies, 1
sigmoid-colectomy and 2 ileostomy reversals. 5 were repeat resections for
recurrent disease at the ileo-colic junction. Prior ileo-colic resection had
occurred in 4 patients, (6 prior resections in 1 patient, 3 in 1 patient and 2 in
2 patients). Open conversion occurred in 1 patient, who had undergone
a prior resection. One anastomotic leak (1/14, 7.1%) occurred, following
primary right-hemicolectomy. Median length of stay in the resection group
was 6.5 days (range 2–11 days). No post-operative deaths occurred.
Conclusion: Laparoscopic techniques may be routinely applied to the
surgical management of Crohn's disease; this includes patients requiring
repeated resections in chronic disease, without signiﬁcant additional
morbidity.
0496: AUDIT OF LYMPH NODE HARVEST DURING BOWEL RESECTION
FOR COLORECTAL CANCER
Kersten Morgan-Bates, James Berwin, Santosh Kumar
Somasundaram, Georgios Akritidis, Olagunju Ogunbiyi. Royal Free
hospital NHS Trust, London, UK
Aims: To perform an audit of lymph node (LN) harvest, an independent
prognostic factor for 5 year survival, during colorectal resections. The
National Bowel Cancer Audit in 2010 identiﬁed that the median number of
LNs excised with the specimen should be15 for colonic cancer and 13 for
rectal cancer.
Methods: Retrospective analysis of prospectively collected data was per-
formed of all eligible patients between January 2010 and August 2011
(20 months).
Results: A total of 177 patients were diagnosed with colorectal cancer
during this study period. 72 patients were excluded for a variety of reasons,
but predominantly for metastatic disease (47). Results from 105 patients
are reported. 93 patients had colon cancer resections. 55 (59.1%) of these
patients had more than 15 LNs excised with the specimen. LNs were
positive in 43 (46.2%). 12 patients underwent surgery for rectal cancer. 9
(75%) of these patients had 13 or more lymph nodes excised with the
specimen. LNs were positive in 4(33.3%).
Conclusions: In a majority, the LN yield following colorectal resection at
our centre was above the National average for rectal and colonic cancers in
this study period, but the surgical technique needs to improve for colonic
resections and a re-audit performed.
0540: LARGE BOWEL OBSTRUCTION CAN BE SAFELY TREATED BY
COLONIC STENT INSERTION - CASE SERIES FROM A UK DISTRICT
GENERAL HOSPITAL
Paul Blake 1, Ray Delicata 2, Nicholas Cross 2, Graham Sturgeon 2, Rachel
Hargest 1. 1University Hospital of Wales, Cardiff, UK; 2Nevill Hall Hospital,
Abergavenny, UK
Aim. The aim of this study is to audit our outcomes and experience of
colonic stent insertion for malignant bowel obstruction.
Methods. Retrospective audit of all stent insertions in a single district
general hospital between August 2003 and December 2009. All patients
had presented with acute bowel obstruction caused by malignant colo-
rectal disease. Details were collected prospectively and contemporaneously
onto a database. Stent insertion was a combined endoscopic and ﬂuoro-
scopic procedure involving a colorectal surgeon and consultant radiologist.
Results. Stenting was attempted on 62 occasions in 54 patients. The
technical success rate was 86% and clinical success rate 84%. The indica-
tions for stenting were relief of acute bowel obstruction, palliation and as
a bridge to surgery. There were complications in fourteen cases (22.5%)
including three perforations and one perioperative mortality. There were
three cases of stent migration, six cases of re-stenosis and two stents
became impacted with stool. There were no incidents of acute or delayed
haemorrhage in any patients.Conclusion. Our experience shows that stenting for obstructing colorectal
cancer is a safe and effective method of alleviating acute and impending
bowel obstruction and can be provided safely and effectively in a district
general hospital.
0560: ANTEGRADE COLONIC ENEMA IN ADULT PATIENTS: A SINGLE
SURGEON SERIES
Mohammed Hamdan, Andrew Gee. Department of Colorectal Surgery, Royal
Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK
Aim: The antegrade colonic enema (ACE) procedure is a minimally
invasive treatment for refractory constipation. 47-83% success rates
have been reported. The aim of this study is to demonstrate the outcome
of patients who underwent the ACE procedure in a district general
hospital.
Methods: Retrospective review of all patients who underwent the ACE
procedure for refractory constipation between February 2002 and June
2011. Demographic, operative and follow up data were recorded.
Results: A total of 12 female patients had the ACE procedure performed by
a single colorectal surgeon. Median age was 43 (24-70) years. Median
postoperative hospital stay was 6 (2-17) days. Median follow up was 36
(14-75) months. Conduit stenosis or leakage developed in 4 and 1 patients
respectively requiring surgical revision.1 patient developed an incisional
herniawith subsequent poor conduit function ultimately managedwith an
end ileostomy. 2 failed to use the conduit and are now on laxatives.
Excluding the latter 3, all patients are managing their constipationwithout
laxatives.
Conclusion: The ACE procedure was successful in 75% of patients who
were, thus, able to avoid more aggressive surgery. Patient education and
compliance are essential to improve success rates.
0566: CHEAPER DOES NOT NECESSARILY MEAN INFERIOR
Stephen Magill, Sylvia Brown, Hoey Koh, Mark Vella, Patrick Finn, Lindsey
Chisholm, Andrew Renwick. Royal Alexandra Hospital, Paisley, UK
Aim: A recent service change at one of our sites (site 2) saw the sole uti-
lisation of endoscopic equipment from a cheaper manufacturer. Endo-
scopists favoured the more expensive equipment and thought that service
quality may be affected. The objective of our study is therefore to evaluate
the effect of change of equipment on service quality.
Methods: Data for 836 colonoscopies performed by three colorectal
surgeons on both sites was prospectively collected.
Results: Overall completion rates were 89.9% at site 1 (n¼490) and 92.2%
at site 2 (n¼346) [p¼0.182]. Completion rates for each consultant also
showed no signiﬁcant differences.
The overall usage of Midazolam between sites were comparable (3.576mg
vs. 3.512mg, p¼0.413), however lower doses were observed for two
consultants at site 2 (3.23mg vs 2.79mg, p¼0.00 and 3.19mg vs 2.95mg,
p¼0.022). The use of analgesics showed no statistical differences between
sites. Comfort score comparison showed no statistical differences overall,
however comfort scoring was signiﬁcantly better at site 2 for two
consultants (p¼0.03 and p¼0.02)
Conclusion: Completion rates, use of sedation and comfort scores are
comparable between the sites despite the difference in equipment.
Thereforewe conclude the quality of service provision is not diminished by
the type of equipment utilised.
0586: IS YOUR BLOOD ORDERING SCHEDULE FOR COLORECTAL
RESECTIONS UP TO DATE AND COMPLIANT WITH NATIONAL
GUIDELINES? AN AUDIT OF CROSS-MATCHED BLOOD UTILISATION IN
ELECTIVE COLORECTAL RESECTIONS (ECR)
Virginie Walker, Jane Hughes, Mandy Chadwick, Naomi
MacKenzie. Wrightington, Wigan & Leigh NHS Foundation Trust, Wigan, UK
Aims: Assess compliancy of our blood ordering schedule against national
guidelines by determining cross-matched blood usage in patients under-
going ECR.
Methods: Retrospective data collection for 12 consecutive months, on ECR
(benign and malignant). Patients requiring preoperative blood transfusion
excluded. Data analysed;operation, pre-operative radiotherapy, preoper-
ative and postoperative haemoglobin, units cross-matched, blood
transfusions.
